ClinicalTrials.govpublic full text
Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls.
hiv-1-infection, hepatic impairment, pharmacokinetics, dolutegravir, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825239
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.